Back to Agendas
Session 7 – Risk Management Planning
Session Chair(s)
Stella Blackburn, MD, MA, MSc, FFPM, FISPE, FRCP
Strategy
Consultant, United Kingdom
Speaker(s)
ADRs, Risks, What is Important...and Can Anyone Tell the Difference Anymore?
Valerie E. Simmons, MD, FFPM
Eli Lilly and Company Ltd, United Kingdom
Senior Medical Fellow, Global Patient Safety
Practical Considerations on Implementing the Pharmacovigilance Plan: Planning Multi-Country PASS
Michelle Bulliard, BSN
IQVIA, Switzerland
Vice President, Global Head Real-World Evidence Strategy Unit
Different Strategies for Risk Minimisation in the EU
Stella Blackburn, MD, MA, MSc, FFPM, FISPE, FRCP
Consultant, United Kingdom
Strategy
Have an account?